Shumaila (2024) “Long-Term Safety and Efficacy of Janus kinase (JAK) Inhibitors in the Treatment of Rheumatoid Arthritis: Disease Control in Rheumatoid Arthritis with JAK Inhibitors”, DEVELOPMENTAL MEDICO-LIFE-SCIENCES, 1(4), pp. 71–78. doi:10.69750/dmls.01.04.039.